Erschienen in:
21.06.2019 | Gastrointestinal Oncology
The Combination of Respiratory Comorbidity and Neoadjuvant Chemoradiotherapy May Double the Risk of Anastomotic Leaks After Esophagectomy: Do We Know Enough to Tailor Neoadjuvant Therapies, or Take Other Preemptive Measures in High-Risk Patients?
verfasst von:
Magnus Nilsson, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 9/2019
Einloggen, um Zugang zu erhalten
Excerpt
The article by Klevebro et al., “Cardiorespiratory comorbidity and postoperative complications following esophagectomy: A European multicenter cohort study,”
1 published in this issue of
Annals of Surgical Oncology, provides new and important insights regarding the impact of comorbidity on complications after esophagectomy, and intriguingly also suggests that there is an interaction between respiratory complications and the type of neoadjuvant therapy. In fact, this study shows a significantly increased risk of anastomotic leaks and pulmonary complications in patients with respiratory comorbidity after neoadjuvant chemoradiotherapy, but not after neoadjuvant chemotherapy or in patients who went straight to surgery. …